BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7589742)

  • 1. Clinical application of HPV typing in cervical cancer.
    Namkoong SE
    Int J Gynaecol Obstet; 1995 Jul; 49 Suppl():S59-67. PubMed ID: 7589742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of human papillomavirus DNA in patients referred to a family practice colposcopy clinic.
    Holman JR
    J Am Board Fam Pract; 1996; 9(3):162-6. PubMed ID: 8743228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus and cervical neoplasia.
    Einstein MH; Goldberg GL
    Cancer Invest; 2002; 20(7-8):1080-5. PubMed ID: 12449741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of human papillomavirus-consensus primers for HPV detection by the polymerase chain reaction.
    Harnish DG; Belland LM; Scheid EE; Rohan TE
    Mol Cell Probes; 1999 Feb; 13(1):9-21. PubMed ID: 10024428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HPV 16 and HPV 18 infection in patients with cervical neoplasia.
    Karaloglu D; Yazici H; Alatli C; Yaman F; Aslay I; Onat H; Dalay N
    Eur J Gynaecol Oncol; 1996; 17(4):296-8. PubMed ID: 8856310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia.
    Villa LL; Sichero L; Rahal P; Caballero O; Ferenczy A; Rohan T; Franco EL
    J Gen Virol; 2000 Dec; 81(Pt 12):2959-2968. PubMed ID: 11086127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of molecular detection of human papillomavirus in cervical samples by hybrid capture technology.
    Vince A; Kutela N; Iscic-Bes J; Harni V; Ivanisevic M; Sonicki Z; Culig Z; Poljak M
    J Clin Virol; 2002 Dec; 25 Suppl 3():S109-12. PubMed ID: 12467785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus testing methods.
    Hubbard RA
    Arch Pathol Lab Med; 2003 Aug; 127(8):940-5. PubMed ID: 12873165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoepithelioma-like carcinoma of the cervix with prominent eosinophilic infiltrate: an HPV-18 associated case.
    Saylam K; Anaf V; Fayt I; Noel JC
    Acta Obstet Gynecol Scand; 2002 Jun; 81(6):564-6. PubMed ID: 12047313
    [No Abstract]   [Full Text] [Related]  

  • 13. Biology and pathological associations of the human papillomaviruses: a review.
    Cheah PL; Looi LM
    Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple 'paper smear' method for dry collection, transport and storage of cervical cytological specimens for rapid screening of HPV infection by PCR.
    Kailash U; Hedau S; Gopalkrishna V; Katiyar S; DAS BC
    J Med Microbiol; 2002 Jul; 51(7):606-683. PubMed ID: 12132779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection and typing of human papillomavirus in biopsy and cytological specimens by polymerase chain reaction and restriction enzyme analysis: a method suitable for semiautomation.
    Adams V; Moll C; Schmid M; Rodrigues C; Moos R; Briner J
    J Med Virol; 1996 Feb; 48(2):161-70. PubMed ID: 8835350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial.
    Richart RM; Masood S; Syrjänen KJ; Vassilakos P; Kaufman RH; Meisels A; Olszewski WT; Sakamoto A; Stoler MH; Vooijs GP; Wilbur DC
    Acta Cytol; 1998; 42(1):50-8. PubMed ID: 9479323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of human papillomavirus in urine and cervical swabs from patients with invasive cervical cancer.
    Stanczuk GA; Kay P; Allan B; Chirara M; Tswana SA; Bergstrom S; Sibanda EN; Williamson AL
    J Med Virol; 2003 Sep; 71(1):110-4. PubMed ID: 12858416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA-EIA to detect high and low risk HPV genotypes in cervical lesions with E6/E7 primer mediated multiplex PCR.
    Clavel C; Rihet S; Masure M; Chypre C; Boulanger JC; Quereux C; Birembaut P
    J Clin Pathol; 1998 Jan; 51(1):38-43. PubMed ID: 9577370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and typing of human papillomavirus DNA by PCR using consensus primers in various cervical lesions of Korean women.
    Hwang T
    J Korean Med Sci; 1999 Dec; 14(6):593-9. PubMed ID: 10642935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.